Hongyan Li

17PUBLICATIONS
35CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)BiomaterialsMain group metal chemistryBacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 23, 2026
A Selective Bis-Catecholate Siderophore-Ampicillin Conjugate Expands Activity against Multidrug-Resistant Pseudomonas aeruginosa.

|Jul 30, 2026
High-throughput bead-based cytokine profiling reveals dynamic immune signatures and identifies candidate exploratory biomarkers in CAR-T therapy.

|Jun 18, 2026
Bismuth drug as an antibiotic adjuvant to inhibit biofilm formation via a dual mechanism.

|Oct 17, 2025
Unprecedented allosteric inhibition of E. coli malate dehydrogenase by silver(i) from atomic resolution analysis.

Haibo Wang, Minji Wang, Xinming Yang

|May 29, 2025
Bismuth drug eradicates multi-drug resistant Burkholderia cepacia complex via aerobic respiration.

Jingru Li, Haibo Wang, Peng Gao

|Sep 18, 2024
Bismuth-based drugs sensitize Pseudomonas aeruginosa to multiple antibiotics by disrupting iron homeostasis.

Yushan Xia, Xueying Wei, Peng Gao

Pageof 3

Frequent Collaborators

17 joint publications

Hongzhe Sun

3 joint publications

Wei Xia

3 joint publications

Pak-Leung Ho

3 joint publications

Xueying Wei